Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Peng-Yuan Zhuang"'
Autor:
Peng-Yuan Zhuang, Jun Shen, Xiao-Dong Zhu, Ju-Bo Zhang, Zhao-You Tang, Lun-Xiu Qin, Hui-Chuan Sun
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58913 (2013)
BACKGROUND: Interferon (IFN)-α is effective in inhibiting tumor growth and metastasis of hepatocellular carcinoma (HCC). However, the biologic mechanisms of IFN-α treatment in lung metastasis are not yet clear. METHODS: The effect of IFN-α treatme
Externí odkaz:
https://doaj.org/article/a2536417c5814f6899260b716809bf8a
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e64598 (2013)
BACKGROUND: Peritumoral liver tissue could play a potential role in hepatocellular carcinoma (HCC) progression and patient survival via angiogenesis- and lymphangiogensis-related factors. The prognostic role of these factors in hepatocytes and stroma
Externí odkaz:
https://doaj.org/article/71f8316ffa12497eb14caa07d4363d5e
Autor:
Zhao-You Tang, Lun-Xiu Qin, Wei-zhong Wu, Lu Wang, Ju-Bo Zhang, Peng-Yuan Zhuang, Xiao-Dong Zhu, Wei Zhang, Hui-Chuan Sun, Yu-Quan Xiong
CCR Translation for the Article from Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f9068a0fd160b1c18018573bad6dd9f
https://doi.org/10.1158/1078-0432.22440844.v1
https://doi.org/10.1158/1078-0432.22440844.v1
Autor:
Zhao-You Tang, Wei-Zhong Wu, Lu Wang, Ling-Qun Kong, Hua-Xiang Xu, Peng-Yuan Zhuang, Yu-Quan Xiong, Hui-Chuan Sun, Xiao-Dong Zhu, Wei Zhang
Supplementary Figure S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::792733ef0e4f3d4b478144a34c56f4d5
https://doi.org/10.1158/1078-0432.22441660
https://doi.org/10.1158/1078-0432.22441660
Autor:
Zhao-You Tang, Lun-Xiu Qin, Wei-zhong Wu, Lu Wang, Ju-Bo Zhang, Peng-Yuan Zhuang, Xiao-Dong Zhu, Wei Zhang, Hui-Chuan Sun, Yu-Quan Xiong
Purpose: Increasing evidence indicates that tumor-derived endothelial cells (TEC) possess a distinct and unique phenotype compared with endothelial cells (NEC) from adjacent normal tissue and may be able to acquire resistance to drugs. The aim of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2554719fd0d7d11ac2056acee8dccd64
https://doi.org/10.1158/1078-0432.c.6518104
https://doi.org/10.1158/1078-0432.c.6518104
Autor:
Zhao-You Tang, Wei-Zhong Wu, Lu Wang, Ling-Qun Kong, Hua-Xiang Xu, Peng-Yuan Zhuang, Yu-Quan Xiong, Hui-Chuan Sun, Xiao-Dong Zhu, Wei Zhang
Purpose: To investigate the role of macrophages in tumor progression under sorafenib treatment and to explore whether combination of drugs that deplete macrophages improved the antitumor effect of sorafenib.Experimental Design: Tumor growth, lung met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34deb753503849a0297226391dea3311
https://doi.org/10.1158/1078-0432.c.6518638
https://doi.org/10.1158/1078-0432.c.6518638
Autor:
Zhao-You Tang, Lun-Xiu Qin, Wei-zhong Wu, Lu Wang, Ju-Bo Zhang, Peng-Yuan Zhuang, Xiao-Dong Zhu, Wei Zhang, Hui-Chuan Sun, Yu-Quan Xiong
Supplementary Data from Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eb5b77fbe415095fe59f4993992d4dc
https://doi.org/10.1158/1078-0432.22440841
https://doi.org/10.1158/1078-0432.22440841
Publikováno v:
Oncology Reports
Interleukin‑6 (IL‑6) is involved in various biological responses, including tumor progression, metastasis and chemoresistance. However, the role and molecular mechanism of IL‑6 in the treatment of sorafenib in liver cancer remain unclear. In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f61b6d2524e2bb5707bd57cd0d031b26
https://pubmed.ncbi.nlm.nih.gov/33432366
https://pubmed.ncbi.nlm.nih.gov/33432366
Autor:
Ke-Wei Zhang, Peng-Yuan Zhuang, Zhiwei Quan, Xue-ping Zhou, Jiandong Wang, Yingbin Liu, Jun Shen
Publikováno v:
Oncotarget
// Peng-Yuan Zhuang 1, * , Ke-Wei Zhang 1, * , Jian-Dong Wang 1 , Xue-Ping Zhou 1 , Ying-Bin Liu 1 , Zhi-Wei Quan 1 and Jun Shen 1 1 Department of General Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb285c3d98de99fe4dab4372b02df09
http://europepmc.org/articles/PMC5652824
http://europepmc.org/articles/PMC5652824
Autor:
Peng-Yuan Zhuang1, Jian-Dong Wang1, Zhao-Hui Tang1, Xue-Ping Zhou1, Zhi-Wei Quan1, Ying-Bin Liu1, Jun Shen1 junshen_xh@163.com, Zhuang, Peng-Yuan2 (AUTHOR), Wang, Jian-Dong2 (AUTHOR), Tang, Zhao-Hui2 (AUTHOR), Zhou, Xue-Ping2 (AUTHOR), Quan, Zhi-Wei2 (AUTHOR), Liu, Ying-Bin2 (AUTHOR), Shen, Jun2 (AUTHOR)
Publikováno v:
BMC Cancer. 11/2/2015, Vol. 15, p1-9. 9p. 1 Chart, 4 Graphs.